SYSTEMATIC REVIEW
Accepted on 21 Apr 2025
Elevated platelet-to-lymphocyte ratio predicts poor clinical outcomes in non-muscle invasive bladder cancer: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1578069
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Innovative Therapeutic Approaches for Complex Cancers: Exploring New Strategies in Glioblastoma, Urogenital, and Bladder Cancers
Innovative Therapeutic Approaches for Complex Cancers: Exploring New Strategies in Glioblastoma, Urogenital, and Bladder Cancers
1,584
Total downloads
6,490
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 17 Apr 2025
A Lactate-Related tSNE Signature Defines Prognostic Subtypes of Bladder Cancer and Reveals LINC01094-Mediated VIM Stabilization in Metastasis and Drug Resistance Author List and Affiliations
doi 10.3389/fimmu.2025.1593523
- 150 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
The role of the LncRNA XIST/miR-15a-5p/MN1 signaling axis in gender disparities in bladder cancer prognosis
doi 10.3389/fimmu.2025.1554829
- 216 views
MINI REVIEW
Accepted on 14 Apr 2025
The Promise of PD1/PDL1 Targeted Immunotherapy in Locally Advanced Cervical Cancer: A Game-Changer for Patients Outcome?
doi 10.3389/fimmu.2025.1573576
ORIGINAL RESEARCH
Accepted on 14 Apr 2025
Identification of SCAMP2 as a Regulator of NOTCH Signaling in Cisplatin Resistance through a Novel Prognostic Model for Bladder Cancer
doi 10.3389/fimmu.2025.1573412
REVIEW
Accepted on 07 Apr 2025
An Update on the Clinical Trial Research of Immunotherapy for Glioblastoma
doi 10.3389/fimmu.2025.1582296
- 174 views
ORIGINAL RESEARCH
Published on 19 Mar 2025
Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model
doi 10.3389/fonc.2025.1539055
- 461 views
ORIGINAL RESEARCH
Published on 27 Feb 2025
Disitamab vedotin vs. gemcitabine-cisplatin regimen with immunotherapy: a comparative analysis of efficacy and safety in muscle-invasive bladder cancer
doi 10.3389/fimmu.2025.1549647
- 685 views
REVIEW
Published on 08 Jan 2025
Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses
doi 10.3389/fimmu.2024.1535647
- 1,566 views
ORIGINAL RESEARCH
Published on 02 Dec 2024
Prognostic model based on disulfidptosis-related lncRNAs for predicting survival and therapeutic response in bladder cancer
doi 10.3389/fimmu.2024.1512203
- 1,044 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: